Get Premium to unlock powerful stock data

ABG Innovation Capital Partners III GP Ltd Buys Aadi Bioscience Inc, Sells Atea Pharmaceuticals Inc, Aerpio Pharmaceuticals Inc

Author's Avatar
insider
Nov 15, 2021
Article's Main Image
Investment company ABG Innovation Capital Partners III GP Ltd (Current Portfolio) buys Aadi Bioscience Inc, sells Atea Pharmaceuticals Inc, Aerpio Pharmaceuticals Inc during the 3-months ended 2021Q3, according to the most recent filings of the investment company, ABG Innovation Capital Partners III GP Ltd. As of 2021Q3, ABG Innovation Capital Partners III GP Ltd owns 6 stocks with a total value of $2 million. These are the details of the buys and sells.

For the details of ABG Innovation Capital Partners III GP Ltd's stock buys and sells, go to https://www.gurufocus.com/guru/abg+innovation+capital+partners+iii+gp+ltd/current-portfolio/portfolio

These are the top 5 holdings of ABG Innovation Capital Partners III GP Ltd
  1. Aadi Bioscience Inc (AADI) - 26,666 shares, 32.53% of the total portfolio. New Position
  2. Genocea Biosciences Inc (GNCA) - 375,000 shares, 29.91% of the total portfolio.
  3. Synlogic Inc (SYBX) - 205,906 shares, 26.09% of the total portfolio.
  4. Pulmonx Corp (LUNG) - 4,521 shares, 6.77% of the total portfolio.
  5. Idera Pharmaceuticals Inc (IDRA) - 56,250 shares, 2.41% of the total portfolio.
New Purchase: Aadi Bioscience Inc (AADI)

ABG Innovation Capital Partners III GP Ltd initiated holding in Aadi Bioscience Inc. The purchase prices were between $0 and $32.66, with an estimated average price of $27.53. The stock is now traded at around $23.540000. The impact to a portfolio due to this purchase was 32.53%. The holding were 26,666 shares as of 2021-09-30.

Sold Out: Atea Pharmaceuticals Inc (AVIR)

ABG Innovation Capital Partners III GP Ltd sold out a holding in Atea Pharmaceuticals Inc. The sale prices were between $21.33 and $35.06, with an estimated average price of $27.69.

Sold Out: Aerpio Pharmaceuticals Inc (ARPO)

ABG Innovation Capital Partners III GP Ltd sold out a holding in Aerpio Pharmaceuticals Inc. The sale prices were between $25.65 and $41.85, with an estimated average price of $31.47.



Here is the complete portfolio of ABG Innovation Capital Partners III GP Ltd. Also check out:

1. ABG Innovation Capital Partners III GP Ltd's Undervalued Stocks
2. ABG Innovation Capital Partners III GP Ltd's Top Growth Companies, and
3. ABG Innovation Capital Partners III GP Ltd's High Yield stocks
4. Stocks that ABG Innovation Capital Partners III GP Ltd keeps buying
Rating:
NaN / 5 ( votes)
Author's Avatar
WRITTEN BY

GuruFocus Screeners

Related Articles

Q&A with Gurus